Biosurfit

About:

Biosurfit develops breakthrough technologies that enable fast, precise and affordable blood analysis at the point of care.

Website: http://www.biosurfit.com

Twitter/X: Biosurfit

Top Investors: Boule Diagnostics, Portugal Ventures, Caixa Capital, PME Investimentos

Description:

At biosurfit they are working to shape the future of in-vitro diagnostic testing. They want health providers to have all the necessary information to make the best possible diagnostic and treatment decision when they are with their patients

Total Funding Amount:

10M EUR

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Lisbon, Lisboa, Portugal

Founded Date:

2006-01-01

Contact Email:

info(AT)biosurfit.com

Founders:

Daniel Neves

Number of Employees:

51-100

Last Funding Date:

2018-12-14

IPO Status:

Private

Industries:

© 2025 bioDAO.ai